Expression patterns of the p53 tumor suppressor gene and the mdm2 protooncogene in human meningiomas

Journal of Neuro-Oncology

Volumn 32, Issue 1, 1997, Pages 39-44

  Pykett, Mark J ^a   Landers, John ^a   George, Donna L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

mdm2; Meningiomas; NF2; p53; Protein overexpression

Indexed keywords

PROTEIN P53;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; MENINGIOMA; PROTO ONCOGENE; TUMOR SUPPRESSOR GENE;

BLOTTING, WESTERN; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; PROTO-ONCOGENES; TUMOR CELLS, CULTURED;

EID: 0031051530     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005779406636     Document Type: Article

References (41)

1. Russell DS, Rubenstein LJ (eds): Pathology of Tumors of the Nervous System. Baltimore: Williams & Wilkins Co., 449-532, 1989
2. Zankl BR, Zang KD: Cytological and cytogenetical studies on brain tumors. Identification of the missing G chromosome in human meningioma as number 22 by fluorescence technique. Hum Genet 14: 167-169, 1972
3. Zang KD: Cytological and cytogenetical studies on human meningioma. Cancer Genet Cytogenet 6: 249-274, 1982
4. Rouleau GA, Mere P, Lutchman M, Sanson M, Zucman J, Marineau C, Huang-Xuan K, Demczuk J, Desmaze C, Plougastel B, Pulst SM, Lenoir G, Bijlsma E, Fashold R, Dumanski J, de Jong P, Parry D, Eldridge R, A, Delattre O, Thomas G: A Iteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363: 515-521, 1993
5. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyal MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, Hasse VH, Ambrose CM, Munroe D, Bove C, Haines JL, Martuza RL, MacDonald ME, Seizinger BR, Short MP, Buckler AJ, Gusella JF: A novel moesin-, ezrin, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor gene. Cell 72: 791-800, 1993
6. LekanneDeprez RH, Bianchi AB, Groen NA, Seizinger BR, Hagemeijer A, van Drunen E, Bootsma D, Koper JW, Avezaat CJJ, Kley N, Zwarthoff EC: Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet 54: 1022-1029, 1994
7. Pykett MJ, Murphy M, Harnish PR, George DL: Identification of a microsatellite instability phenotype in meningiomas. Cancer Res 54: 6340-6343, 1994
8. Ruttledge MH, Sarrazin J, Rangaratnam S, Phelan CM, Twist E, Merel P, Delattre O, Thomas G, Nordenskjold M, Collins VP, Dumanski JP, Rouleau GA: Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nature Genet 6: 180-184, 1994
9. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 253: 49-53, 1991
10. Levine AJ, Momand J, Finlay CA : The p53 tumour suppressor gene. Nature 351: 453-456, 1991
11. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM: The E6 protein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 67: 547-556, 1990
12. Werness BA, Levine AJ, Howley PM: Association of human papillomavirus types 16 and 18 with p53. Science 248: 76-79, 1990
13. Mietz JA, Unger T, Huilgregtse JM, Howley PM: The transcriptional transactivation of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J 11: 5013-5020, 1992
14. Anker L, Ohgaki H, Ludeke BI, Hermann H-D, Kleihaus P, Westphal M: p53 protein accumulation and gene mutations in human glioma cell lines. Int J Cancer 55: 982-987, 1993
15. Macgeoch C, Barnes DM, Newton JA, Mohammed S, Hodgson SV, Ng M, Bishop DT, Spurr NK: p53 protein detected by immuno-histochemical staining is not always mutant. Disease Markers 11: 239-250, 1993
16. Rubio M, vonDeimling A, Yandell DW, Wiestler OD, Gusella JF, Louis DN: Accumulation of wild type p53 protein in human astrocytomas. Cancer Res 53: 3465-3467, 1993
17. Weiss J, Schwechheimer K, Cavenee WK, Herlyn M, Arden KC: Mutation and expression of the p53 gene in malignant melanoma cell lines. Int J Cancer 54: 693-699, 1993
18. Hinds PW, Finlay CA, Quartin RS, Baker JS, Fearon ER, Vogelstein B, Levine AJ: Mutant p53 DNA clones from human colon carcinomas cooperate with rad in transforming primary rat cells: a comparison of the 'hot spot' mutant phenotype. Cell Growth Differ 1: 571-580, 1990
19. Cahilly-Snyder L, Yang-Feng T, Francke U, George DL: Molecular analysis and chromosome mapping of amplified genes isolated from a transformed mouse 3T3 cell line. Somatic Cell Mol Genet 13: 235-244, 1987
20. Fakharzadeh SS, Trusko SP, George DL: Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J 10: 1565-1569, 1991
21. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B: Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358: 80-83, 1992
22. Ladanyi M, Cha C, Lewis R, Jhanwar SC, Huvos AG, Healy JH: MDM2 gene amplification in metastatic osteosarcoma. Cancer Res 53: 16-18, 1993
23. Leach FS, Tokino T, Meltzer P, Burrell M, Oliner JD, Smith S, Hill DE, Sidrandky D, Kinzler KW, Vogelstein B:p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res 53: 2231-2234, 1993
24. Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP: Amplification and overexpression of the MDM2 gene in a subset of malignant gliomas without p53 mutations. Cancer Res 53: 2736-2739, 1993
25. Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, Marechal V, Chen J, Brennan MF, Levine AJ: Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res 54: 794-799, 1994
26. Momand J, Zambetti GP, Olson DC, George D, Levine AJ: The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237-1245, 1992
27. Haines DS, Landers JE, Engle LJ, George DL: Physical and functional interaction between wild-type p53 and mdm2 proteins. Mol Cell Biol 14: 1171-1178, 1994
28. Borresen A-L, Hovig E, Smith-Soresen B, Malkin D, Lystad S, Andersen TI, Nesland JM, Isselbacher KJ, Friend SH: Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations. Proc Natl Acad Sci USA 88: 8405-8409, 1991
29. Davidoff AM, Pence JC, Shorter NA, Ingelhart JD, Marks JR: Expression of p53 in human neuroblastoma- and neuroepithelioma-derived cell lines. Oncogene 7: 127-133, 1992
30. Moll UM, Riou G, Levine AJ: Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci USA 89: 7262-7266, 1992
31. Landers JE, Haines DS, Strauss II JF, George DL: Enhanced translation: A novel mechanism of mdm2 overexpression identified in human tumor cells. Oncogene 9: 2745-2750, 1994
32. Murphy M, Chen J, George DL: Establishment and characterization of a leptomeningeal cell line. J Neurosci Res 30: 475-483, 1991
33. Saylors III RL, Sidransky D, Friedman HS, Bigner SH, Bigner DD, Vogelstein B, Brodeur GM: Infrequent p53 gene mutations in medulloblastomas. Cancer Res 51: 4721-4723, 1991
34. Ohgaki H, Eibl RH, Wiestler OD, Yasargil MG, Newcomb EW, Kleihues P: p53 mutations in nonastrocytic brain tumors. Cancer Res 51: 6202-6205, 1991
35. Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM: p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res 52: 674-679, 1992
36. Florenes VA, Oyjord T, Holm R, Skrede M, Borresen AL, Nesland JM, Fodstad O: TP53 allele loss, mutations and expression in malignant melanoma. Br J Cancer 69: 253-259, 1994
37. Karamitopoulou E, Perentes E, Diamantis I: p53 protein expression in central nervous system tumors: an immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodies. Acta Neuropathol 85: 611-616, 1993
38. Ellison DW, Lunec J, Gallagher PJ, Steart PV, Jaros E, Gatter KC: Accumulation of wild-type p53 in meningiomas. Neuropath Appl Neurobiol 21: 136-142, 1995
39. Gudas JM, Oka M, Diella F, Trepel J, Cowan KH: Expression of wild-type p53 during cell cycle in normal human mammary epithelial cells. Cell Growth Diff 5: 295-304, 1994
40. Ionov Y, Peinado MA, Malkhosyan S, Shabata D, Perucho M: Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363: 558-561, 1993
41. Mironov NM, Aguelon MA, Potapova GI, Omori Y, Grobunov OV, Klimenkov AA, Yamasaki H: Alterations of (CA)n DNA repeats and tumor suppressor genes in human gastric cancer. Cancer Res 54: 41-44, 1994